HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 33, 23818-23828, August 17, 2007

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 282/33/23818    most recent M701078200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, I. H. Articles by Mucke, L. Search for Related Content PubMed PubMed Citation Articles by Cheng, I. H. Articles by Mucke, L. Social Bookmarking                      What's this?

Accelerating Amyloid- Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models^*

Irene H. Cheng, Kimberly Scearce-Levie, Justin Legleiter, Jorge J. Palop, Hilary Gerstein, Nga Bien-Ly, Jukka Puoliväli¹, Sylvain Lesné^¶, Karen H. Ashe^¶, Paul J. Muchowski^||, and Lennart Mucke²

From the Gladstone Institute of Neurological Disease, San Francisco, California 94158, the Departments of Neurology and ^||Biochemistry and Biophysics, University of California, San Francisco, California 94143, and the ^¶Department of Neurology, University of Minnesota Medical School, Minneapolis, Minnesota 55455

Many proteins suspected of causing neurodegenerative diseases exist in diverse assembly states. For most, it is unclear whether shifts from one state to another would be helpful or harmful. We used mutagenesis to change the assembly state of Alzheimer disease (AD)-associated amyloid- (A) peptides. In vitro, the "Arctic" mutation (AE22G) accelerated A fibrillization but decreased the abundance of nonfibrillar A assemblies, compared with wild-type A. In human amyloid precursor protein (hAPP) transgenic mice carrying mutations adjacent to A that increase A production, addition of the Arctic mutation markedly enhanced the formation of neuritic amyloid plaques but reduced the relative abundance of a specific nonfibrillar A assembly (A*56). Mice overexpressing Arctic mutant or wild-type A had similar behavioral and neuronal deficits when they were matched for A*56 levels but had vastly different plaque loads. Thus, A*56 is a likelier determinant of functional deficits in hAPP mice than fibrillar A deposits. Therapeutic interventions that reduce A fibrils at the cost of augmenting nonfibrillar A assemblies could be harmful.

Received for publication, February 5, 2007 , and in revised form, May 30, 2007.

^* This work was supported in part by National Institutes of Health Grants AG011385, AG022074, and AG023501 (to L. M.), NS33249 (to K. H. A.), and a Facilities Grant (RR 18928-01) from the National Institutes of Health National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1, Figs. S1–S4, and Movies S1 and S2.

¹ Present address: Cerebricon Ltd., 70211 Kuopio, Finland.

² To whom correspondence should be addressed: 1650 Owens St., San Francisco, CA 94158. Tel.: 415-734-2504; Fax: 415-355-0131; E-mail: lmucke{at}gladstone.ucsf.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. M. Douglas, S. Treusch, H.-Y. Ren, R. Halfmann, M. L. Duennwald, S. Lindquist, and D. M. Cyr Chaperone-dependent amyloid assembly protects cells from prion toxicity PNAS, May 20, 2008; 105(20): 7206 - 7211. [Abstract] [Full Text] [PDF]

				W. J. Meilandt, G.-Q. Yu, J. Chin, E. D. Roberson, J. J. Palop, T. Wu, K. Scearce-Levie, and L. Mucke Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease J. Neurosci., May 7, 2008; 28(19): 5007 - 5017. [Abstract] [Full Text] [PDF]